The drug, ADCETRIS, is a new intravenous drug that came to the table to help support the war against cancer. Seattle Genetics entered into agreements with companies like GlaxoSmithKline, ADC Technology and Pfizer to develop various drugs for cancer patients. The FDA has approved ADCETRIS for use in 65 countries for its fine qualities.
The reason that Clay B. Siegal was so dedicated to the development of cancer medications was that the subject hit home for him. His father came down with cancer, and he wanted to find the right product to help the patients stay healthier for longer periods of time. He felt that he was capable of developing something that would be much better than anything else that was previously put on the market.
Dr. Siegall took a brief interview that explained his position on drugs, cancer and entrepreneurship. He has a lot of sound advice because he has been in business for more than 20 years of his life. Before he founded Seattle Genetics, he has spent some time with Bristol-Myers Squibb, the National Cancer Institute, and the National Institutes of Health. He has a B.S. in zoology and a Ph.D. in genetics. As far as business goes, Dr. Siegal is a superstar. He has received awards and recognition such as Alumnus of the Year from the University of Maryland.
Dr. Siegal ended his interview with some sound advice for people who want to become successful entrepreneurs. His advice to such people is to learn as much as possible. There is always more that a person can learn even when he thinks he knows it all. Another thing that Dr. Siegal mentioned during his interview was the message of teamwork. He said that most of his company’s success came about because of the collaborations that he did with other companies. Working with other companies allows the original company to grab hold of some additional skills without having to re-attend school. Third-party collaborations are usually good because they balance things and give everyone the opportunity to contribute something positive and then shine. Siegal hopes to see a brighter day for cancer patients and other people who are still trying to keep the faith.